Isolation of the highly pathogenic and zoonotic agent Burkholderia pseudomalleifrom a pet green Iguana in Prague, Czech Republic by Mandy C Elschner et al.
Elschner et al. BMC Veterinary Research 2014, 10:283
http://www.biomedcentral.com/1746-6148/10/283CASE REPORT Open AccessIsolation of the highly pathogenic and zoonotic
agent Burkholderia pseudomallei from a pet green
Iguana in Prague, Czech Republic
Mandy C Elschner1*, Jan Hnizdo2, Ivonne Stamm3, Hosny El-Adawy1, Katja Mertens1 and Falk Melzer1Abstract
Background: Melioidosis caused by Burkholderia (B.) pseudomallei is an endemic zoonotic disease mainly reported
from northern Australia and Southeast Asia. In Europe, cases of human melioidosis have been reported only from
patients travelling to endemic regions. Besides humans, B. pseudomallei has a very broad host range in domestic
and wild animals. There are some reports about importation of B. pseudomallei-infected animals from endemic
areas into Europe. The present report describes the first case of B. pseudomallei infection of a pet iguana in Europe.
Case presentation: In a 5-year-old pet Iguana iguana living in a private household in Prague, Czech Republic,
B. pseudomallei was isolated from pus of an abscess. The isolate VB976100 was identified by Vitek®2, MALDI-TOF
mass spectrometry and polymerase chain reaction as B. pseudomallei. The molecular typing resulted in multi-locus
sequence type 436 hitherto, which has been found only once worldwide in a B. pseudomallei strain isolated in the
USA and originating from Guatemala. The identification as internal transcribed spacer type G indicates a close
relatedness to strains mainly isolated in the Western Hemisphere. These findings support the hypothesis that the
iguana became infected in this region or in a breeding facility through contact to other infected animals.
Conclusions: The present case highlights the risk of importation of the highly pathogenic and zoonotic
B. pseudomallei into non-endemic regions through animal trade. Therefore, veterinarians treating animals from these
areas and physicians examining patients owning such animals should include melioidosis in differential diagnosis
whenever specific symptoms appear. Furthermore, veterinary authorities responsible for supervision of traders and
pet shops should be aware of this risk of zoonotic transmission.
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Burkholderia (B.) pseudomallei is the causative agent of
melioidosis, an endemic disease mainly reported from
northern Australia and Southeast Asia. In this area the
disease has emerged as an important cause of morbidity
and mortality during the last 25 years [1]. Endemic and
sporadic cases of melioidosis are also reported from
countries of South America, North America, Oceania, as
well as Aruba, Guadeloupe, Guam, Haiti, Martinique,
and Puerto Rico. Increasing numbers of cases are reported
from Africa [2]. However, in Europe cases of human* Correspondence: mandy.elschner@fli.bund.de
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unless otherwise stated.melioidosis have only reported from patients who had
been travelling to endemic regions [3,4]. The gram-
negative bacterium belongs to biohazard risk group 3
agents, is listed as biowarfare agent, and has to be proc-
essed under biosafety level 3 conditions. The disease is
mainly acquired environmentally by percutaneous infec-
tion, ingestion, or inhalation. The incubation period of
melioidosis can vary between one day and 62 years, de-
pending on the route of infection and infection dose [1].
Clinical studies have shown that pneumonia is the pre-
dominant clinical manifestation, followed by skin and soft
tissue infections, as well as acute suppurative parotitis, es-
pecially in pediatric cases, and prostatitis in males [5]. One
predominant risk factor is diabetes mellitus, as shown by
studies in Australia and Thailand, where up to 60% of the
melioidosis patients are diabetic, mainly type 2 [5].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Elschner et al. BMC Veterinary Research 2014, 10:283 Page 2 of 5
http://www.biomedcentral.com/1746-6148/10/283Besides humans, B. pseudomallei has a very broad host
range. In domestic animals it is most commonly re-
ported in cattle, goats and swine [6]. However, sporadic
cases or small outbreaks have been reported in monkeys,
gibbons, orangutans, kangaroos, wallabies, deer, buffaloes,
cows, camels, llamas, zebras, koalas, dogs, cats, horses,
mules, parrots, rats, hamsters, rabbits, guinea pigs, ground
squirrels, seals, dolphins, crocodiles [7]. Very recently, B.
pseudomallei infections in two pet iguanas in California
were reported [8]. In animals, acute and chronical form of
melioidosis is seen. Common symptoms in animals in-
clude anorexia, pyrexia, coughing, skin dehydration and
abscesses [7,9].
Case presentation
The female Iguana iguana was purchased by private
owners as a young animal from a pet shop in Prague in
2009. It was kept alone in a terrarium, but was also allowed
to move freely outside the cage in the flat (Figure 1). The
owners had a very close and tender contact to the animal,
such as hand feeding and kissing. Usually the iguana was
fed with special pellet formulation for iguanas, fresh
green salad, vegetables and fruits, and once a month byFigure 1 The infected animal: 5-year-old female green iguana (IguanaZophobas morio larvae purchased from different breeders.
In 2011, the animal developed an abscess underneath the
left eye, which was transected and treated antibiotically
without microbiological investigation. In 2013, the animal
was admitted to the Animal Clinic, Bila Hora, Prague,
Czech Republic, where again an abscess was diagnosed,
this time at the root of the tongue. After surgical interven-
tion and antibiotic treatment by marbofloxacine the
animal recovered. One year later, in 2014 the owners pre-
sented the animal again to the clinic because of a week-
long anorexia. The clinical investigation resulted again in
an encapsulated abscess located at the root of the tongue.
This time the abscess was sampled for microbiological
analysis. As soon as the first suspicion of a B. pseudomallei
infection was announced, the veterinary authority was in-
formed, and it mandated the immediate euthanization and
incineration of the animal. One veterinary assistant was
bitten by the iguana when he tried to fix the maxilla for
sampling of the abscess by the veterinarian. The skin was
injured although he wore gloves. Finally, the wound was
cured and the assistant was prophylactically treated with
amoxicillin-clavulanate for 10 days in a clinic specialized
for infectious diseases. Also the owners, not showing anyiguana).
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examination and received the same treatment. Serological
investigations were not induced in the contact persons,
because the physicians could not find a laboratory provid-
ing this analysis. Unfortunately, no information about
follow up examinations of the contact persons is available.
Isolation, identification, and molecular characterisation of
B. pseudomallei
For microbiological diagnosis, the pus from the abscess
was submitted on a swab with Amies transport medium
(D&D Laborservice, Henningsdorf, Germany) to the Vet
Med Labor GmbH, Ludwigsburg, Germany. The sample
was cultured on MacConkey agar (BioMerieux, Nürtin-
gen, Germany), tryptic soy agar with 5% sheep blood,
chocolate agar (both BD, Heidelberg, Germany) and in-
cubated at 36°C under atmosphere with 5% CO2 for
24 hours, and afterwards for 24 hours in ambient atmos-
phere. Additionally, brain heart infusion enrichment
broth was inoculated and sub-cultured for 24 hours on
the same agar media as above. Heavy growth of metallic
gleaming navel forming colonies was visible in pure
culture after 48-h incubation on all culture media. The
isolate VB976100 could also be grown at 42°C, but not
at 4°C. It showed a positive Oxidase reaction (VWR,
Darmstadt, Germany) and was tested negative for cata-
lase (Sigma-Aldrich Chemie GmbH, Munich, Germany).
Short gram-negative rods with bipolar “safety pin” ap-
pearance were visible after Gram staining (Figure 2).
Identification with Vitek®2 (BioMerieux) resulted in B.
pseudomallei with 95% probability, corresponding to a
very good validity of identification. The same identification
result was obtained with MALDI-TOF mass spectrometry
(Biotyper Microflex LT, Bruker Daltonics GmbH, Bremen,Figure 2 Gram-stain of B pseudomallei isolate VB976100, phase
contrast microscopy with a 100 x oil immersion objective
(Microscope Leica DM4000B).Germany) with very high score values of >2.600 corre-
sponding to highly probable species identification.
For confirmation of B. pseudomallei and further char-
acterization, the culture was sent to the Federal Research
Institute for Animal Health, Jena, Germany. The isolate
VB976100 was cultured under biosafety level 3 condi-
tions and the typical shape of colonies was seen on
Ashdown-Agar [10] after 72 h (Figure 3).
Molecular identification was performed by real-time
PCR detecting B. mallei/pseudomallei-specific sequences
of the fliC gene [11] and B. pseudomallei-specific se-
quences of the orf2 gene, which belongs to the type III
secretion system [12].
Multi-locus sequence typing (MLST), the predominant
method for molecular subtyping of B. pseudomallei was
performed by comparison of 7 housekeeping genes [13].
The isolate was typed as sequence type (ST) 436 by the
B. pseudomallei database of MLST.Net [14], and data
have been deposited there. This ST has been only
isolated in California from a patient originating from
Guatemala in 2012 [15]. However, for an isolate of un-
known origin, MLST alone is not adequate for determin-
ation of the geographic origin [15,16]. Therefore, we
performed the 16S-32S internal transcribed spacer (ITS)
typing [16]. For identification of the ITS type, the
obtained sequence data were aligned to known ITS
types A, B, C, D, E, and G, available data at GenBank
(FJ981703-F981726) using the Software Geneious 6.1.8.
(Biomatters Development Team). Our B. pseudomallei
isolate VB976100 was typed as ITS type G (613 base
pairs), and the ITS sequence was annotated and submitted
to GenBank under the accession number KP069478.
Conclusions
Import of B. pseudomallei infected animals from en-
demic areas has been previously reported in sheep, goats
and pigs from Aruba [17]. In the 1970s a B. pseudomal-
lei outbreak was reported in the zoo of Paris, and the in-
fection was spread to other zoos and equestrian clubs.
In the course of this outbreak, termed “l’affaire du jardin
des plantes”, two individuals died. Imported horses from
Iran or an imported panda from China were assumed as
sources of infection [18,19].
B. pseudomallei infections in green iguanas were
already detected in California, USA, in 2007 and 2012.
The bacteria were isolated from the abscess, as well as
from the animal housing [8]. In both cases the isolates
were typed as ST 518 and ITS type G. The authors
suggested that the animals had been infected in Central
America, where most imported iguanas in the USA origin-
ate from. Furthermore, these cases already highlighted the
possible risk of human infections because the infection in
the iguanas was not curable in spite of refractory antibiotic
treatment. In one of these cases after the incubation
Figure 3 Colonies of B. pseudomallei isolate VB976100 on Ashdown agar showing the typical pink crinkled colonies after 72 h incubation.
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the clinical course of the present reported B. pseudomallei
infection, the animal developed abscesses at the age of 2, 4
and 5 years. However, there was no known history of any
kind of trauma, which potentially could have triggered the
development of abscesses [8,20]. Unfortunately, only in
2014 bacteriological examination was initiated. It is specu-
lative but possible that after an incubation period of 2 years
the first abscess was caused by a B. pseudomallei infection.
These finding strongly supports the presumption, that in
these animals a long incubation period is seen, bearing a
risk of long not recognized phase of shedding and here-
with infection risk for contact persons.
The iguana was purchased as a young animal in 2009,
and unfortunately, it was not possible to determine the
origin of this animal. However, the ST 436 was hitherto
described for one B. pseudomallei strain, isolated in
USA, originating from Guatemala [15]. On the other
hand, the ITS type G of B. pseudomallei is a less com-
mon type in endemic regions, such as Australia and
Southeast Asia. This type seems to be associated with
isolates found only in sporadic melioidosis regions like
Africa and South America [15,16]. These findings sup-
port the hypothesis that the iguana became infected in
this region or in a breeding facility through contact to
other infected animals originating from this area.
Our report emphasizes the risk of importation of B.
pseudomallei into non-endemic regions through animal
trade. It is possible that for patients presenting charac-
teristic symptoms of melioidosis but with absolutely no
history of travelling to endemic regions, the attendingphysician could misdiagnose or overlook the suspicion
of melioidosis. The utility of a post exposure prophylaxis
in contact persons should be discussed with the physi-
cians. Recommendations for prophylaxis and treatment
are available from Bossi et al. [21].
Personal safety can be improved by wearing eye pro-
tection and suitable gloves during sampling and treat-
ment of possibly affected animals. For the serological
investigations in non-endemic areas IgG ELISA could be
useful to identify chronically infected persons [22]. Since
no standardized commercial tests are available only spe-
cialized laboratories can perform such investigations.
Although we are unable to prove the source of infec-
tion in the present case, veterinarians involved in treat-
ment of animals and competent veterinary authorities
responsible for supervision of traders should be aware of
this potential risk.
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